In our latest article, we explore how PMC supports Dr Kathrine Scott of Gedeon Richter with new product launches and day to day copy approval. Read on to learn how we are helping this small medical team make a real impact.
The number of clinical trials for orphan conditions has grown significantly in the past decade. New advances in genomics and artificial intelligence also stand to improve prospects for patients with rare diseases. Read the article to learn how PharmaMedic helps translate often complex science into stakeholder value for rare disease sponsors and deliver new medicines to patients who need them.
PharmaMedic Consultancy is delighted to announce its sponsorship of the ‘Excellence in Rare Diseases and Orphan Drugs" category at the 2020 Pharmaceutical Market Excellence Awards (PMEA).
From 1 January 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) will be making independent regulatory decisions. Guidelines are in place, and the ABPI has called for support to help sponsors navigate the changes. Read on to learn more about this new era of independence for the agency.
In our latest article, we explore how PharmaMedic Consultancy (PMC®) supports Glenmark Pharmaceuticals with their day to day promotional activities. Read on to learn how our medical affairs consultant seamlessly fits into our client's team and ensures commercial compliance.
Collaboration is essential to drive innovation in pharma and bring new medicines to patients. In this article, we discuss how close cooperation between regulatory and medical affairs helps to streamline regulatory interactions.
In this second article in our consultant Q&A series, we sat down with Sarah Hollywood, to learn about her experiences working on medical affairs projects with PharmaMedic. If you’re thinking of taking the plunge into medical or regulatory affairs consultancy, read the article for Sarah’s account of life as a PharmaMedic consultant.
In this new article, we sit down with Lucy Cook, one of the PharmaMedic Consultancy network to talk about her experience in medical affairs, work-life balance, and how PharmaMedic Consultancy helps her to do more of the technical work she enjoys without the traditional headaches of self-employment.
Now more than ever, we need to apply old-fashioned common sense to help drive advances in healthcare. In this article we discuss how reconfiguring and repurposing of medicines have come to the fore during the COVID-19 pandemic.
With the COVID-19 pandemic disrupting medical provision across the globe, healthcare providers urgently need to improve efficiency of patient care. Read our new article to learn how artificial intelligence is being used in clinical decision-making.
